Drug shortage
Amino Acid Injection · Baxter Healthcare
FDA drug shortage · Current · updated Apr 7, 2025
Key facts
| Generic name | Amino Acid Injection |
|---|---|
| Proprietary name | Travasol |
| Company | Baxter Healthcare |
| Presentation | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100… |
| Dosage form | Injection |
| Strength | 1.03 g/100 mL 1.15 g/100 mL 180 mg/100 mL 2.07 g/100 mL 40 mg/100 mL 400 mg/100 mL 420 mg/100 mL 480 mg/100 mL 500 mg/100 mL 560 mg/100 mL 580 mg/100 mL 600 mg/100 mL 680 mg/100 mL 730 mg/100 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Gastroenterology |
| Package NDCs | 0338-0644-04 |
| First posted | Dec 8, 2020 |
| Last updated | Apr 7, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: